GamaMabs Pharma announces presentation of murlentamab phase 2 study results in colorectal cancer at ESMO World Congress on Gastrointestinal Cancer
Minoryx Therapeutics announces first patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia
GamaMabs Pharma to present updated results at 2019 ASCO Annual Meeting from the First-In-Human clinical study of murlentamab in advanced gynecological cancers
Neuroprotection Biotech Bionure Reports Successful Phase 1 Study for Lead Candidate BN201
CarThera publishes complete results of Phase I/IIa clinical trial using its SonoCloud-1 ultrasound implant for treatment of glioblastoma
HypnoVR confirms validity of virtual reality hypnosis through three clinical studies
Alizé Pharma 3 to present data from its AZP-3404 program at ENDO 2019
Pherecydes Pharma reports successful patient treatment with bacteriophages
